Zhangchuan Xia

Zhangchuan Xia

Auto-generated profile, based on publicly available information

Zhangchuan Xia

Institute for Cancer Genetics, Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center, New York, NY, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2025 in Nature
Verified
Journal Article
Closed access
PDF file
XZXiaofei Zhi
Xiaofei Zhi
FWFeijing Wu
Feijing Wu
JQJin Qian
Jin Qian
YOYosuke Ochiai
Yosuke Ochiai
GLGuodong Lian
Guodong Lian
TWTimothy Wang
Timothy Wang

7 June 2024 in Science Advances
Verified
Journal Article
Open access
ZSZhenyi Su
Zhenyi Su
YLYanqing Liu
Yanqing Liu
ZXZhangchuan Xia
Zhangchuan Xia
ARAnil K. Rustgi
Anil K. Rustgi
WGWei Gu
Wei Gu
We have found that the ketogenic (Keto) diet is able to, unexpectedly, promote the metastatic potential of cancer cells in complementary mouse models. Notably, the Keto diet–induced tumor metastasis is dependent on BTB domain and CNC homolog 1 (BACH1) and its up-regulation of pro-metastatic targets, including cell migration–inducing hyaluronidase 1, in response to the Keto diet. By contrast, upon genetic knockout or pharmacological inhibition of endogenous BACH1, the Keto diet–mediated activation of those targets is largely diminished, and the effects on tumor metastasis are completely abolished. Mechanistically, upon administration of the Keto diet, the levels of activating transcription factor 4 (ATF4) are markedly induced. Through direct interaction with BACH1, ATF4 is recruited to those pro-metastatic target promoters and enhances BACH1-mediated transcriptional activation. Together, these data implicate a distinct transcription regulatory program of BACH1 for tumor metastasis induced by the Keto diet. Our study also raises a potential health risk of the Keto diet in human patients with cancer.

1 May 2017 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
ZXZhangchuan Xia
Zhangchuan Xia
GXGang Xu
Gang Xu
XYXiaodan Yang
Xiaodan Yang
NPNanfang Peng
Nanfang Peng
Qi ZuoQi Zuo
Qi Zuo
YZYing Zhu
Ying Zhu
The innate immune response is critical for host defense and must be tightly controlled, but the molecular mechanisms responsible for its negative regulation are not yet completely understood. In this study, we report that transporter 1, ATP-binding cassette, subfamily B (TAP1), a virus-inducible endoplasmic reticulum–associated protein, negatively regulated the virus-triggered immune response. In this study, we observed upregulated expression of TAP1 following virus infection in human lung epithelial cells (A549), THP-1 monocytes, HeLa cells, and Vero cells. The overexpression of TAP1 enhanced virus replication by inhibiting the virus-triggered activation of NF-κB signaling and the production of IFNs, IFN-stimulated genes, and proinflammatory cytokines. TAP1 depletion had the opposite effect. In response to virus infection, TAP1 interacted with the TGF-β–activated kinase (TAK)1 complex and impaired the phosphorylation of TAK1, subsequently suppressing the phosphorylation of the IκB kinase complex and NF-κB inhibitor α (IκBα) as well as NF-κB nuclear translocation. Our findings collectively suggest that TAP1 plays a novel role in the negative regulation of virus-triggered NF-κB signaling and the innate immune response by targeting the TAK1 complex.

25 June 2025 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
ZXZhangchuan Xia
Zhangchuan Xia
NKNing Kon
Ning Kon
ZSZhenyi Su
Zhenyi Su
JYJingjie Yi
Jingjie Yi
XHXu Hua
Xu Hua
WGWei Gu
Wei Gu

5 May 2026 in Nature
Verified
Journal Article
Closed access
XZXiaofei Zhi
Xiaofei Zhi
FWFeijing Wu
Feijing Wu
JQJin Qian
Jin Qian
YOYosuke Ochiai
Yosuke Ochiai
GLGuodong Lian
Guodong Lian
TWTimothy Wang
Timothy Wang